Danone Acquires Functional Formularies
Danone Acquires Functional Formularies
Press release – Paris, May 01, 2024
新聞稿 — 巴黎，2024 年 5 月 1 日
Danone acquires Functional Formularies
達能收購功能性配方
Danone announces today it has successfully completed the acquisition of Functional Formularies, a leading whole foods tube feeding business in the US, from Swander Pace Capital.
達能今天宣佈，它已成功完成對Swander Pace Capital對美國領先的全食管飼料業務功能配方的收購。
As part of the Renew Danone strategy, this acquisition strengthens Danone's Medical Nutrition portfolio in the US by further expanding its enteral tube feeding ranges.
作爲Renew Danone戰略的一部分，此次收購通過進一步擴大其腸內管餵養範圍，加強了達能在美國的醫療營養產品組合。
Juergen Esser, Deputy CEO and CFO, said:
副首席執行官兼首席財務官尤爾根·埃瑟說：
"As a global leader in Medical Nutrition, we are delighted to welcome Functional Formularies to Danone. We are confident that with the addition of the greatly differentiated product portfolio of Functional Formularies, which complements our existing Real Food Blends branded range, we are even better positioned to support the nutritional needs of tube-fed families and patients."
“作爲醫學營養領域的全球領導者，我們很高興歡迎功能性配方加入達能。我們相信，隨着差異化極大的功能性配方產品組合的增加，這是對我們現有的Real Food Blends品牌系列的補充，我們更有能力滿足管喂家庭和患者的營養需求。”
About Functional Formularies
關於功能性配方
Functional Formularies is a leading provider of organic, whole food, shelf-stable feeding tube formulas. The Company offers unique, organic, and whole food alternatives to traditional feeding tube formulas. Liquid Hope and Nourish are nutritionally complete, plant-based, and USDA-certified organic. The Company offers its products to institutional customers in hospital and long-term care settings and to retail customers online throughout the U.S. and Canada. To learn more about Functional Formularies products, visit .
功能性配方是有機、全食、可保質期的飼料管配方的領先供應商。該公司爲傳統的餵食管配方奶粉提供獨特、有機和全食物替代品。液態希望 並滋養 營養完整，以植物爲基礎，經美國農業部認證的有機食品。該公司向醫院和長期護理機構的機構客戶以及美國和加拿大的在線零售客戶提供其產品。要了解有關功能性配方產品的更多信息，請訪問 。
About Danone ()
關於達能 ()
Danone is a leading global food and beverage company operating in three health-focused, fast-growing and on-trend Categories: Essential Dairy & Plant-Based products, Waters and Specialized Nutrition. With a long-standing mission of bringing health through food to as many people as possible, Danone aims to inspire healthier and more sustainable eating and drinking practices while committing to achieve measurable nutritional, social, societal and environment impact. Danone has defined its "Renew" strategy to restore growth, competitiveness, and value creation for the long-term. With almost 90,000 employees, and products sold in over 120 markets, Danone generated €27.6 billion in sales in 2023. Danone's portfolio includes leading international brands (Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, among others) as well as strong local and regional brands (including AQUA, Blédina, Bonafont, Cow & Gate, Mizone, Oikos and Silk). Listed on Euronext Paris and present on the OTCQX platform via an ADR (American Depositary Receipt) program, Danone is a component stock of leading sustainability indexes including the ones managed by Moody's and Sustainalytics, as well as MSCI ESG Indexes, FTSE4Good Index Series, Bloomberg Gender Equality Index, and Access to Nutrition Index. Danone's ambition is to be B CorpTM certified at global level in 2025.
達能是一家全球領先的食品和飲料公司，經營三個注重健康、快速增長和流行趨勢的類別：基本乳製品和植物性產品、水和特殊營養。達能的長期使命是通過食物爲儘可能多的人帶來健康，旨在激發更健康、更可持續的飲食習慣，同時致力於實現可衡量的營養、社會、社會和環境影響。達能已經定義了其 “更新” 戰略，以恢復長期增長、競爭力和價值創造。達能擁有近9萬名員工，產品銷往120多個市場，在2023年創造了276億歐元的銷售額。達能的產品組合包括領先的國際品牌（Actimel、Activia、Alpro、Aptamil、Danette、Danio、Danonino、evian、Nutricia、Nutrilon、Volvic，除其他外）以及強大的本地和區域品牌（包括 AQUA、Ble'dina、Bonafont、Cow & Gate、Mizone、Oikos 和 絲綢）。在巴黎泛歐交易所上市並在OTCQX平台上市 通過 達能是一項ADR（美國存託憑證）計劃，是領先的可持續發展指數的組成股，包括穆迪和Sustainalytics管理的指數，以及摩根士丹利資本國際ESG指數、富時社會責任指數系列、彭博性別平等指數和營養獲取指數。達能的目標是成爲 B CorpTM 2025 年獲得全球認證。
o o O o o
o o o o o o o o
FORWARD-LOOKING STATEMENTS
前瞻性陳述
This press release contains certain forward-looking statements concerning Danone. In some cases, you can identify these forward-looking statements by forward-looking words, such as "estimate", "expect", "anticipate", "project", "plan", "intend", "objective", "believe", "forecast", "guidance", "foresee", "likely", "may", "should", "goal", "target", "might", "will", "could", "predict", "continue", "convinced" and "confident," the negative or plural of these words and other comparable terminology. Forward looking statements in this document include, but are not limited to, predictions of future activities, operations, direction, performance and results of Danone.
本新聞稿包含有關達能的某些前瞻性陳述。在某些情況下，您可以通過前瞻性詞語來識別這些前瞻性陳述，例如 “估計”、“預期”、“項目”、“計劃”、“打算”、“目標”、“相信”、“預測”、“指導”、“預見”、“可能”、“應該”、“目標”、“可能”、“可能”、“預測””、“繼續”、“確信” 和 “自信”，這些詞的否定或複數形式以及其他類似的術語。本文檔中的前瞻性陳述包括但不限於對達能未來活動、運營、方向、業績和業績的預測。
Although Danone believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in these forward-looking statements. For a detailed description of these risks and uncertainties, please refer to the "Risk Factor" section of Danone's Universal Registration Document (the current version of which is available at ).
儘管達能認爲其預期基於合理的假設，但這些前瞻性陳述存在許多風險和不確定性，這可能導致實際業績與這些前瞻性陳述中的預期存在重大差異。有關這些風險和不確定性的詳細描述，請參閱達能通用註冊文件的 “風險因素” 部分（該文件的當前版本可在以下網址獲取） )。
Subject to regulatory requirements, Danone does not undertake to publicly update or revise any of these forward-looking statements. This document does not constitute an offer to sell, or a solicitation of an offer to buy Danone securities.
在遵守監管要求的前提下，達能不承諾公開更新或修改任何前瞻性陳述。本文件不構成出售要約，也不構成購買達能證券要約的邀請。
Attachment
附件
- danonepr010524
- danonepr010524
譯文內容由第三人軟體翻譯。